MUNICH (MedPage Today) -- Once again a percutaneous coronary intervention -- this time the paclitaxel-eluting Taxus stent -- was proven inferior to coronary artery bypass surgery, though by a narrower margin than in past head-to-head trials.
ESC: Bypass Surgery Trumps Stents for Complex Coronary LesionsCourtesy MedPage Today Surgery Mon, 09/01/2008 - 12:51
MUNICH (MedPage Today) -- Once again a percutaneous coronary intervention -- this time the paclitaxel-eluting Taxus stent -- was proven inferior to coronary artery bypass surgery, though by a narrower margin than in past head-to-head trials. Tags:
More related itemsACC: No Winner Found in Left Main Disease (CME/CE)
N.Y. Stenting Often Means Return Visit to Hospital...
Post-Stent Bleeding Signals Long-Term Risk (CME/CE)
Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
|
Popular by tags WeekMonth |
Post new comment